IQVIA Launches AI-Powered Predictive Clinical Development
Research Triangle Park, North Carolina — September 3, 2026 IQVIA announced the launch of IQVIA Predictive Clinical Development, an...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Research Triangle Park, North Carolina — September 3, 2026 IQVIA announced the launch of IQVIA Predictive Clinical Development, an...
MORRISVILLE, N.C., August 18, 2026 Syneos Health announced continued expansion of its AI-powered clinical development ecosystem, bringing together artificial...
WARREN, N.J. and ROYAL OAK, Mich., February 26, 2026 Tevogen Bio Holdings Inc. (Nasdaq: TVGN) has signed a non-exclusive,...
